Clinical trials
Terminated Phase 1 Sarcoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
60 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 2 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 4 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 3 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 5 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 6 |
| 2020 | 2 |
| 2021 | 5 |
| 2022 | 7 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 60 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 6 |
| Masonic Cancer Center, University of Minnesota | 3 |
| Pfizer | 3 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 3 |
| M.D. Anderson Cancer Center | 2 |
| Shanghai PerHum Therapeutics Co., Ltd. | 2 |
| Wake Forest University Health Sciences | 2 |
| Washington University School of Medicine | 2 |
| Y-mAbs Therapeutics | 2 |
| ADC Therapeutics S.A. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sarcoma | 60 |
| Melanoma | 16 |
| Breast Neoplasms | 13 |
| Neoplasms | 10 |
| Colorectal Neoplasms | 8 |
| Ovarian Neoplasms | 8 |
| Pancreatic Neoplasms | 8 |
| Carcinoma, Non-Small-Cell Lung | 7 |
| Carcinoma, Renal Cell | 7 |
| Lung Neoplasms | 7 |
Trials
Showing 1 to 25 of 60. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.